CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab

Trial StartForalumabPositive
AI Analysis

Summary

Tiziana Life Sciences announced the first participants have been dosed in the BANYAN clinical trial of intranasal foralumab for ALS treatment.

Clinical Trial Data

Outcome Details

First participants dosed in BANYAN clinical trial

Importance:4/10
Sentiment:
0.30
clinical trialALSintranasalmonoclonal antibody
Related Companies
$TLSA

Read the original article

Published by yahoo_finance on September 28, 2026 11:00 AM

Read Original